91 related articles for article (PubMed ID: 22661555)
1. Antibodies to hnRNPs in patients with a systemic rheumatic disease with no antibodies to extractable nuclear antigens or dsDNA.
De Beéck KO; Vermeersch P; Verschueren P; Westhovens R; Mariën G; Blockmans D; Bossuyt X
Rheumatology (Oxford); 2012 Aug; 51(8):1515-6. PubMed ID: 22661555
[No Abstract] [Full Text] [Related]
2. Autoantibodies to heterogeneous nuclear ribonucleoproteins.
Caporali R; Bugatti S; Bruschi E; Cavagna L; Montecucco C
Autoimmunity; 2005 Feb; 38(1):25-32. PubMed ID: 15804702
[TBL] [Abstract][Full Text] [Related]
3. Antinuclear antibody titer and antibodies to extractable nuclear antigens.
Bossuyt X; Hendrickx A; Frans J
Arthritis Rheum; 2005 Dec; 53(6):987-8. PubMed ID: 16342092
[No Abstract] [Full Text] [Related]
4. [Antibodies against soluble nuclear antigens in rheumatic diseases].
Nikolov K; Baleva M
Vutr Boles; 1987; 26(5):112-7. PubMed ID: 3324484
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.
Chloraki-Bobota A; Megalakaki C; Repousis P; Chalkiopoulou I; Lalaki I; Trafalis DT; Athanassiou AE; Mitsouli-Mentzikof C
J BUON; 2006; 11(4):485-9. PubMed ID: 17309182
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus.
Faria AC; Barcellos KS; Andrade LE
J Rheumatol; 2005 Jul; 32(7):1267-72. PubMed ID: 15996063
[TBL] [Abstract][Full Text] [Related]
7. Italian multicentre study for application of a diagnostic algorithm in autoantibody testing for autoimmune rheumatic disease: conclusive results.
Bonaguri C; Melegari A; Ballabio A; Parmeggiani M; Russo A; Battistelli L; Aloe R; Trenti T; Lippi G
Autoimmun Rev; 2011 Nov; 11(1):1-5. PubMed ID: 21741498
[TBL] [Abstract][Full Text] [Related]
8. Multiplex assessment of non-organ-specific autoantibodies with a novel microbead-based immunoassay.
Grossmann K; Roggenbuck D; Schröder C; Conrad K; Schierack P; Sack U
Cytometry A; 2011 Feb; 79(2):118-25. PubMed ID: 21265005
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous nuclear RNPs as targets of autoantibodies in systemic rheumatic diseases.
Op De Beéck K; Maes L; Van den Bergh K; Derua R; Waelkens E; Van Steen K; Vermeersch P; Westhovens R; De Vlam K; Verschueren P; Hooijkaas H; Blockmans D; Bossuyt X
Arthritis Rheum; 2012 Jan; 64(1):213-21. PubMed ID: 21905010
[TBL] [Abstract][Full Text] [Related]
10. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases.
Sharp GC; Irvin WS; May CM; Holman HR; McDuffie FC; Hess EV; Schmid FR
N Engl J Med; 1976 Nov; 295(21):1149-54. PubMed ID: 1086429
[TBL] [Abstract][Full Text] [Related]
11. Application of a combined protocol for rational request and utilization of antibody assays improves clinical diagnostic efficacy in autoimmune rheumatic disease.
Tampoia M; Brescia V; Fontana A; Zucano A; Morrone LF; Pansini N
Arch Pathol Lab Med; 2007 Jan; 131(1):112-6. PubMed ID: 17227110
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
[TBL] [Abstract][Full Text] [Related]
13. [Significance of antinuclear antibodies in rheumatology].
Ciobanu V; Boloşiu HD
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1986; 38(2):97-111. PubMed ID: 2875509
[No Abstract] [Full Text] [Related]
14. Testing for antibodies to ENA and to dsDNA is not indicated in FANA-negative sera.
Manoussakis MN; Garalea KL; Tzioufas AG; Moutsopoulos HM
Clin Rheumatol; 1988 Dec; 7(4):465-9. PubMed ID: 3073034
[TBL] [Abstract][Full Text] [Related]
15. [Comparison between line immunoassay (LIA) and enzyme-linked immunosorbent assay (ELISA) for the determination of antibodies to extractable nuclear antigenes (ENA) with reference to other laboratory results and clinical features].
Maclachlan D; Vogt P; Wu X; Rose L; Tyndall A; Hasler P
Z Rheumatol; 2002 Oct; 61(5):534-44. PubMed ID: 12399881
[TBL] [Abstract][Full Text] [Related]
16. Comparison of automated multiplexed bead-based ANA screening assay with ELISA for detecting five common anti-extractable nuclear antigens and anti-dsDNA in systemic rheumatic diseases.
Kim Y; Park Y; Lee EY; Kim HS
Clin Chim Acta; 2012 Jan; 413(1-2):308-11. PubMed ID: 22027339
[TBL] [Abstract][Full Text] [Related]
17. Relationship between snRNA species contained in nuclear antigens recognized by autoantibodies and the clinical profile in systemic rheumatic diseases.
Assens C; Graafland H; Liautard JP; Sri-Widada J; Brunel C; Jeanteur P
Biomed Pharmacother; 1982; 36(3):134-9. PubMed ID: 6185159
[TBL] [Abstract][Full Text] [Related]
18. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
19. [Anti-extractable nuclear antigen antibody].
Imafuku Y
Nihon Rinsho; 2010 Jun; 68 Suppl 6():514-6. PubMed ID: 20942117
[No Abstract] [Full Text] [Related]
20. Origin and structure of autoantibodies and antigens in autoimmune rheumatic diseases.
Rahman A; Stollar BD
Lupus; 2008 Mar; 17(3):232-5. PubMed ID: 18372367
[No Abstract] [Full Text] [Related]
[Next] [New Search]
